Future mechanistic studies may address the role of LDLR and SREBP-2 proteins as well as potential differences in external cholesterol dependency, cholesterol uptake potential, and post-translationally regulated HMGCR degradation in statin resistance of different human breast cancer cell types. This evidence concerns the gene SREBF2 and breast carcinoma.